Across TCGA pan-cancer cohorts, COA4 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated COA4 data layer compared with 26 for mass-spec protein and 5 for mass-spec protein.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher COA4 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated COA4 expression acts as an unfavorable survival marker.
LUAD are the cancer types where COA4 Mutation most reproducibly stratifies survival.